Andy Hill is a highly experienced professional in the health technology industry, with a background in life sciences and an MBA. With over 30 years of expertise, he has held leadership positions up to the CEO level in companies like Sēon Diagnostics Ltd, Fieldridge, Michelson Diagnostics Ltd, and more. His vast experience spans international sales, marketing, and general management, particularly within the US and European healthcare systems. Andy has a strong track record in developing and executing strategies for the successful introduction of new medical technologies across various clinical areas. His specialties include health technology, fundraising, investor relations, global sales, marketing, product introduction strategies, product development, clinical evaluation oversight, and reimbursement strategy. Educationally, he holds an MBA in Business Administration and a BSc in Botany and Biochemistry from Open Business School and Durham University, respectively.